Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Prepaid Assets (2021 - 2025)

Historic Prepaid Assets for InMed Pharmaceuticals (INM) over the last 5 years, with Q3 2025 value amounting to $191755.0.

  • InMed Pharmaceuticals' Prepaid Assets rose 2879.66% to $191755.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $191755.0, marking a year-over-year increase of 2879.66%. This contributed to the annual value of $321747.0 for FY2025, which is 3265.35% down from last year.
  • As of Q3 2025, InMed Pharmaceuticals' Prepaid Assets stood at $191755.0, which was up 2879.66% from $321747.0 recorded in Q2 2025.
  • InMed Pharmaceuticals' 5-year Prepaid Assets high stood at $1.3 million for Q1 2022, and its period low was $140512.0 during Q4 2021.
  • For the 5-year period, InMed Pharmaceuticals' Prepaid Assets averaged around $563948.8, with its median value being $498033.0 (2023).
  • In the last 5 years, InMed Pharmaceuticals' Prepaid Assets skyrocketed by 48851.27% in 2022 and then tumbled by 5014.44% in 2025.
  • InMed Pharmaceuticals' Prepaid Assets (Quarter) stood at $140512.0 in 2021, then skyrocketed by 488.51% to $826931.0 in 2022, then skyrocketed by 34.59% to $1.1 million in 2023, then tumbled by 42.14% to $643986.0 in 2024, then plummeted by 70.22% to $191755.0 in 2025.
  • Its Prepaid Assets stands at $191755.0 for Q3 2025, versus $321747.0 for Q2 2025 and $507872.0 for Q1 2025.